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Abstract
Background: The myogenic capacity of satellite cells (SCs), adult muscle stem cells, is influenced by aging, exercise,
and other factors. In skeletal muscle, the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is a
key regulator of oxidative metabolism and endurance training adaptation. However, a link between PGC-1α and SC
behavior remains unexplored.
Methods: We have now studied SC function in a PGC-1α fiber-specific gain-of-function animal model.
Results: In surprising contrast to bona fide exercise, muscle-specific PGC-1α transgenic mice have lower SC
numbers. Nevertheless, SCs from these mice have a higher propensity for activation and proliferation. Intriguingly,
muscle PGC-1α triggers a remodeling of the SC niche by altering the extracellular matrix composition, including the
levels of fibronectin, which affects the proliferative output of SCs.
Conclusions: Taken together, PGC-1α indirectly affects SC plasticity in skeletal muscle and thereby might contribute
to improved SC activation in exercise.
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Background
Satellite cells (SC) are adult muscle stem cells located at
the periphery of muscle fibers between the sarcolemma
and basal lamina (BL) [1], in the vicinity of blood vessels
and the neuromuscular junction [2]. SCs are accordingly
exposed to various signals from within and outside of
the fiber, which collectively comprise the specific envir-
onment termed the SC niche. Although metabolically in-
active and quiescent in resting conditions, SCs quickly
become activated in response to a stimulus such as in-
jury or strenuous exercise [3]. These stem cells are indis-
pensable for skeletal muscle regeneration [4], and
despite being present in relatively small numbers (2–5%
of total myonuclei), SCs have a vast proliferative and re-
generative potential [3].
Proper activation and proliferation, as well as return to
quiescence, are all essential to preserving SC number
and function. In various pathological contexts, for ex-
ample, in certain muscular dystrophies or aging, a deple-
tion of SC numbers is linked to impaired regenerative
capacity [5]. Importantly, reduced SC numbers and myo-
genic activity are often caused by alterations of the SC
niche. For example, excess fibronectin (FN) in the BL in
an uninjured state is correlated with a reduced ability of
SCs to respond to injury [6]. Age-associated accumula-
tion of extracellular matrix (ECM) components leads to
the thickening of the BL [7], thereby preventing SCs
from sensing changes in the environment and resulting
in a reduced activation propensity. Inversely, treatment
with fibronectin can restore satellite cell activation in
old muscle [8]. Moreover, local transient FN secretion
by SCs is an important step in the cascade of SC activa-
tion and subsequent proliferation [9], and such a transi-
ent increase in FN muscle expression is necessary for
successful regeneration [8].* Correspondence: christoph.handschin@unibas.ch1Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056 Basel,
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SC numbers vary by muscle fiber type, with higher
counts present in oxidative compared to glycolytic
muscle beds [10]. In line with this, endurance exercise
increases SC numbers in mice and humans [11, 12]. The
peroxisome proliferator-activated receptor γ coactivator
1α (PGC-1α) is a major driver of oxidative fiber-type
specification, mitochondrial biogenesis, and high endur-
ance capacity [13]. Furthermore, PGC-1α gene expres-
sion is induced by exercise and exhibits a preference for
slow, oxidative fibers [14]. Finally, muscle-specific over-
expression of PGC-1α protects against a variety of
muscle-wasting conditions, including fiber atrophy or
the pathologies in dystrophic mouse models [15]. Never-
theless, a potential link between PGC-1α, oxidative fi-
bers, exercise, and SCs has not been studied yet. By
using a mouse model which specifically overexpresses
PGC-1α in adult muscle fibers, we attempted to delin-
eate the aforementioned missing link and assess the im-
portance of indirect effects of PGC-1α on SC phenotype.
Here, we show that muscle fiber PGC-1α modulates
SC number as well as proliferation and that the latter, at
least in part, could be regulated by the altered expres-
sion of ECM components, including FN protein levels,
in the BL. Increased PGC-1α content in the SC niche
therefore results in an accelerated SC response to injury
and higher myogenic capacity.
Methods
Animals
Muscle-specific PGC-1α-transgenic animals that express
transgenic PGC-1α under the control of the muscle cre-
atine kinase (MCK) promoter have been described
(mTGs) [14]. Male 8–16 week-old animals were used
unless stated otherwise. All animal experimental proce-
dures performed in this study were approved by the
Cantonal and institutional authorities.
Cardiotoxin injury
Mice were anesthetized using an O2/sevoflurane gas
mixture (3% sevoflurane). The lower part of the hind
limbs was shaved and the belly region of the tibialis
anterior (TA) muscle injected with the control vehicle
(30 μl of PBS) or cardiotoxin (30 μl containing 3 μg
of CTX, C9759 Sigma) using insulin syringes (U-100,
300 μl, 29G × 1/2 in.). Mice were sacrificed and mus-
cles collected at various time points. In the case of
multiple CTX injuries — our model of chronic in-
jury — CTX was injected three times (with a 3-week
period of rest between each injection) and muscles
were collected 3 weeks after the last injury. TAs were
transversally cut into two pieces and frozen for hist-
ology or RNA isolation.
Immunohistochemistry (IHC)
The TA, extensor digitorum longus (EDL), and soleus
(SOL) muscles were collected immediately after sacri-
fice, covered by OCT (Tissue-Tek, Sakura), and
frozen in isopentane precooled in liquid nitrogen.
Frozen muscles were cut into 8 μm-thick sections
using a cryostat (Leica CM1950) and kept at −20 °C
until staining. The sections were dried at room
temperature (RT), fixed in 4% paraformaldehyde
(PFA), permeabilized in methanol, and antigen-
retrieved in a citrate buffer using a microwave oven.
After blocking (1 h at RT) and overnight (o/n) incu-
bation at 4 °C with primary antibodies, the sections
were washed with PBS, incubated with secondary
antibodies for 1.5 h at RT, then washed again, and
mounted with Vectashield including DAPI. Blocking
was performed using 1:100 diluted mouse IgG Fab
fragment (015-000-007, Jackson ImmunoResearch) in
3% bovine serum albumin (BSA) in PBS. The primary
antibodies used are Pax7 (DSHB) and laminin
(ab11575 Abcam). The secondary antibodies used are
biotin goat anti-mouse IgG Fcγ1 (115-065-205 Jack-
son ImmunoResearch), streptavidin Alexa568 (S11226
Invitrogen), and goat anti-rabbit Alexa488 (A11008
Invitrogen).
Fiber isolation, fiber culture, and immunocytochemistry
Muscle fibers were isolated from the EDL muscle of
12–16-week-old animals as described in detail else-
where [16]. Briefly, isolated muscles were digested in
2 mg/ml collagenase A (Roche Diagnostics) solution
(DMEM, 2 mM L-glutamine, 1% antibiotic cocktail)
for 1.5 h and fibers further separated using trituration
with glass Pasteur pipettes. Single fibers were fixed ei-
ther immediately (T0) in 10% PFA or after a 3-day
incubation (T3) in culture media (DMEM, 2 mM L-
glutamine, 10% fetal bovine serum, 0.5% chicken em-
bryo extract, 1% antibiotic cocktail). Fixed fibers were
permeabilized in 0.5% Triton X-100 in PBS, blocked
with 20% horse serum in PBS for 30 min at RT, and
incubated with the primary antibodies against Pax7
(DSHB) and MyoD C-20 (sc-304) as well as DAPI o/
n at 4 °C. After washing with PBS, fibers were incu-
bated with the secondary antibodies goat anti-mouse
IgG1 Alexa568 (A21124 Invitrogen) and goat anti-
rabbit Alexa488 (A11008 Invitrogen) for 1.5 h at RT,
washed with PBS, and mounted on glass slides with
Vectashield.
Myoblast isolation, culture, and immunocytochemistry
Myoblasts (MBs) were isolated from the EDL of 2–
3 week-old male mice using a single fiber-based tech-
nique [17]. EDL fibers were separated using collagenase
A (Roche Diagnostics) and incubated in plastic dishes
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coated with matrigel (BD Biosciences). After several
days, proliferating myoblasts emerging from fibers
were propagated in culture media (HyClone DMEM,
10% horse serum, 20% fetal bovine serum, 1%
chicken embryo extract, 2 mM L-glutamine, 5 ng/ml
basic fibroblast growth factor, 1% antibiotic cocktail)
and used for assessing myoblast proliferation rates.
For that purpose, equivalent numbers of cells were
plated on plastic dishes in low concentration and
fixed in 4% PFA after different incubation periods
(e.g., 2 and 4 days post-plating). Cells were perme-
abilized in 0.5% Triton X-100 in PBS, blocked with
3% BSA in PBS, and incubated o/n at 4 °C with the
primary antibody against desmin (ab15200) in 3%
BSA in PBS. After washing with PBS, cells were in-
cubated for 1 h at RT with the secondary antibody
goat anti-rabbit IgG Cy3 (111-165-045 Jackson
ImmunoResearch), washed with PBS, and mounted
using Vectashield with DAPI.
Image acquisition and quantification
For IHC, images covering the whole area of muscle
transversal sections were captured using a Zeiss LSM700
microscope with the Zen 2010 software and a 25x ob-
jective with a 0.5 zoom. SC numbers (Pax7+/DAPI+)
were expressed per area unit for all muscles. Section
area was measured using the ImageJ software and fiber
Feret minimum assessed using the Analysis or ImageJ
software. In the fiber culture experiment, satellite cell
and myoblast numbers were quantified on approximately
60 fibers/mouse for T0 or approximately 20 fibers/
mouse for T3 and expressed per fiber. In the case of iso-
lated MBs, single cells were quantified prior to fixation
on 10 random fields on a Leica DMI4000B microscope
using a 10x objective or alternatively after staining (des-
min+/DAPI+) on 100 fields on a Zeiss LSM700 micro-
scope using a 10x objective. MB quantification was done
by hand or with the help of the Imaris software. All
quantifications were performed in a blind manner.
RNA extraction and semiquantitative PCR (qPCR)
RNA was isolated from muscles using lysing matrix
tubes (MP Biomedicals) and TRI Reagent (Sigma) ac-
cording to the manufacturer’s instructions, and concen-
tration was measured with a Nanodrop 1000 (Thermo
Scientific). One microgram of RNA was digested with
DNase I (Invitrogen), after which complementary DNA
(cDNA) synthesis was performed by reverse transcrip-
tion with Superscript II (Invitrogen). qPCR measure-
ments were done on a StepOne instrument with SYBR
green-based detection and used for assessing relative
gene expression levels. TATA-binding protein (TBP)
served as a housekeeping gene, and relative expression
was calculated with the ΔΔCt method. Additional file 1
lists all of the qPCR primers.
Protein isolation and immunoblot analysis
Protein isolation and immunoblot analysis was per-
formed as described previously [18]. Briefly, muscle tis-
sue was homogenized in ice-cold RIPA buffer and
protein concentration determined by Bradford Assay.
After diluting and denaturating the samples in Laemmli
Sample Buffer, 30 μg protein per sample was run on an
8% SDS-polyacrylamide gel. To improve the transfer of
larger proteins to the nitrocellulose membrane, the etha-
nol concentration in the transfer buffer was reduced to
10% and SDS was added to a final concentration of
0.1%. Following the 90-min transfer at a constant voltage
of 100 V, protein transfer was verified by Ponceau stain-
ing. The membrane was blocked in 5% BSA for 60 min
and incubated overnight at 4 °C with primary antibodies.
For protein detection, the following antibodies were
used: fibronectin (FN, ab2413, Abcam; dilution 1/1000),
α-tubulin (2125, Cell Signaling; dilution 1/1000), and
polyclonal swine anti-rabbit immunoglobulins/HRP
(P0399, Dako; dilution 1/3000 for FN and 1/10,000 for
α-tubulin). After incubating the membranes in enhanced
chemiluminescence reagent (Pierce 32106 or 34080), the
western blots were visualized (Fusion Fix, Vilber Lour-
mat) and quantified (ImageJ software, National Institutes
of Health). Samples were normalized to the expression
of α-tubulin.
Muscle contractility measurements in situ
In situ isometric muscle contractility as a method for
assessing muscle regeneration has been previously de-
scribed [15]. Briefly, pentobarbital solution (60 mg/kg)
was intraperitoneally administered to mice in order to
ensure deep anesthesia. The hind paws and knees were
fixed to a platform and distal tendons of the TA muscles
attached to an isometric transducer (Harvard Bio-
science). 0.1-ms supramaximal square wave pulses were
used for sciatic nerve stimulation, the contractions were
measured at muscle length L0 (the length yielding max-
imum tension during tetanus), and the data were re-
corded and analyzed with the PowerLab software (4SP,
AD Instruments). Maximal tetanic force (P0) and spe-
cific force (P0/weight) were determined by measuring
muscle response to tetanic stimulation (6.25, 12.5, 25,
50, 100, and 143 Hz) and muscle mass. Fatigue resist-
ance was expressed as the time needed for the P0 of the
muscle to drop to half its initial value and was measured
with one continuous contraction (50 Hz for 45 s). Over-
dose of pentobarbital solution was used to sacrifice the
mice at the end of the experiment.
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Statistical analysis
Data are expressed as average (AV) ± SEM. Gene expres-
sion values from CTX-injected muscles were normalized to
the PBS values by means of unpaired assessment unless
stated otherwise. Statistical analysis was based on Student’s
t test and used for comparison of two genotypes under the
same conditions. p ≤ 0.05 was interpreted as significant.
Results
PGC-1α overexpression in muscle reduces SC numbers
mTGs have muscles with a higher percentage of oxida-
tive at the expense of glycolytic fibers [14]. The trans-
genic muscles are also rich in blood vessels and have
greater endurance compared to wild-type (WT) muscles.
Inversely, muscle-specific knockout mice exhibit the op-
posite phenotype [19]. In parallel to PGC-1α expression,
SC numbers are higher in oxidative muscle beds [10]
and can further be boosted by exercise [11, 12]. Thus, to
directly test the effect of muscle PGC-1α on SCs, we
assessed SC numbers in mTGs, a gain-of-function model
for PGC-1α for which overexpression is restricted to the
mature muscle fiber. For that purpose, the SCs (Pax7
+/DAPI+ cells) on cross sections of TAs were quantified,
and unexpectedly, lower SC numbers in mTGs were re-
vealed (Fig 1a). A similar reduction in SC numbers was
also observed in the soleus of mTGs compared to WT
mice (Fig 1b), contrary to the specific enrichment of SCs
in oxidative muscle beds that occurs in WT animals.
Next, the basal gene expression of Pax7 and myogenic
regulatory factors (MRFs) in mTG TA muscles was de-
termined (Fig 1c). Pax7 is a transcription factor that is
specifically expressed in quiescent and activated SCs
[20]. Upon activation, SCs increase in size, enter the cell
cycle, and start expressing the MRFs Myf5 and MyoD,
thereby becoming myoblasts. Some of the proliferating
Pax7+/MyoD+ cells will continue on the differentiation
path with an ensuing reduction in Pax7 and boost in
myogenin gene expression. They will subsequently exit
the cell cycle and form mononucleated postmitotic myo-
cytes that will then, with increasing expression of MRF-
4, start fusing in order to form myotubes. In mTGs, a
decrease in the expression of the MRFs Myf5 and MRF-
4 as well as Pax7 was detected (Fig 1c). Thus, the modu-
lation of basal SC numbers was reflected in the regula-
tion of MRF gene expression, in particular that of Pax7.
PGC-1α levels affect SC proliferation after CTX injury
SCs are muscle stem cells that are activated upon injury,
at which point they enter the cell cycle and proliferate in
order to regenerate damaged muscle [3]. A decrease in
Fig 1 SC numbers, MRF expression, and SC proliferation after cardiotoxin injection. a SC numbers per area in TA (n = 4 per group), b SOL and
EDL muscles (n = 4 per group) of mTGs and WTs. c Relative mRNA levels of Pax7 and MRFs in TA (n = 6 per group) of mTGs compared to controls
(WT); mRNA levels in mTG were normalized to littermate control levels. d SC numbers per area 4 days post-CTX (n = 7–8 per group) and e 19 days
post-CTX (n = 8–10 per group) in mTGs together with representative IHC images (laminin: green, DAPI/nuclei: blue; Pax7: red). Red rectangles de-
note enlarged areas of sections, and SCs are marked with white asterisks. Brightness/contrast was adjusted using ImageJ. Values are plotted as AV
± SEM; *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001
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SC numbers is a hallmark of chronic diseases such as
Duchenne muscular dystrophy (DMD) but is also seen
during aging [5, 21]. We therefore investigated whether
the lower numbers of SCs in mTGs also affect the
ability of muscle to cope with an acute injury. SCs in
TA cross sections were quantified 4 and 19 days after
CTX-induced muscle damage (Fig 1d, e). We ob-
served a trend towards higher proliferative output in
mTGs at 4 days post-CTX (Fig 1d). At the 19-day
time point, a significant increase in the relative SC
number in mTGs was recorded (Fig 1e). Thus, basal
SC number did not correlate with SC proliferation
upon muscle injury.
To study the time course of myogenesis in regener-
ation, we next measured Pax7 and MRF gene expres-
sion profiles in TA muscle during recovery after
injury caused by CTX (Additional file 2). Similar to
the altered SC activation seen in histological prepara-
tions, we observed exacerbated dynamics of the myo-
genic gene expression changes in injured compared to
PBS-injected mTGs vis-à-vis the changes in injured
compared to PBS-injected WT animals. Specifically, a
higher increase in Pax7 and MyoD (Additional file 2A
and 2B) in the early days of regeneration followed by
their decline and a subsequent rise in expression
levels of myogenin and MRF-4 (Additional file 2C
and 2D) in the later days were detected in the mTGs
vis-à-vis the more attenuated changes in the WTs.
Notably, MRF gene expression changes in the two ge-
notypes converged at later time points, e.g., at 19 days
after CTX injection (Additional file 2). Accordingly,
in situ contractility experiments did not reveal any
significant differences between mTGs and WT mice
in regard to absolute force (Additional file 3A), spe-
cific force (Additional file 3B), or fatigue resistance
(Additional file 3C) at a late stage of muscle regener-
ation. This was also in line with the indistinguishable
recovery of fiber sizes at 19 days after CTX injection
(Additional file 3D and 3E) in the two genotypes.
Thus, modulation of muscle PGC-1α seems to pre-
dominantly affect early stages of SC activation.
Given the observed increase in SC proliferative out-
put in vivo upon injury in mTGs (Fig 1d, e), we won-
dered if this might perturb the processes of SC
renewal and consequently lead to SC depletion, which
would affect future rounds of regeneration in these
mice. To address this question, we performed triple
CTX injuries as a chronic injury model and assessed
SC numbers as well as fiber size distribution 3 weeks
after the last injection (Additional file 4). Although a
certain reduction in SC proliferative output was found
in mTGs (Additional file 4A), SCs were not lost even
in this model of profound repetitive injury. Moreover,
regeneration progressed without obstacles and even
proceeded faster in mTGs as evidenced by larger fi-
bers (Additional file 4B and 4C).
PGC-1α modulates the SC niche
Skeletal muscle regeneration is a very complex process
that involves the participation of muscle fibers, SCs, and
various other cell types [22]. To study the effects of
muscle PGC-1α on the early events in SC activation, we
used an ex vivo approach based on isolation and culture
of single muscle fibers together with SCs in which SC
numbers on freshly isolated fibers (T0) and the SC pro-
liferative output after 3 days in culture (T3) were quanti-
fied (Fig 2). First, this ex vivo experiment revealed lower
numbers of SCs (Pax7+/DAPI+) per fiber originating
from mTG animals (Fig 2a, b), as observed in the study
in vivo (Fig 1a). Next, the quantification of quiescent
SCs (Pax7+/MyoD−/DAPI+), committed progenitors
(Pax7+/MyoD+/DAPI+), and myoblasts (Pax7−/MyoD
+/DAPI+) per fiber at T3 revealed a higher relative pro-
liferative output (T3/T0) in mTGs (Fig 2c–g), again in
line with the in vivo observations (Fig 1d, e).
Subsequently, we tested the proliferative output of SCs
outside of their niche. Primary myoblasts were isolated
and their proliferative rate determined (Fig 3). The pur-
ity of the primary population was verified by desmin
staining. Myoblast proliferation was assessed by com-
paring cell numbers between two incubation periods
in order to minimize the influence of variations in
the number of cells plated. Quantification was per-
formed on live cells (Fig 3a), as well as on fixed and
stained myoblasts (Fig 3b). In either case, we did not
observe any differences in the proliferation rates be-
tween mTG and WT myoblasts. Thus, since the
modulation of SC activation is lost in this experiment
and not in the ex vivo fiber culture, the results to-
gether indicate a predominant role of the fiber-
associated SC niche in mediating the observed effects
of PGC-1α on SC proliferation rates.
The stem cell niche influences SC proliferation in the
PGC-1α mouse model
Intriguingly, we observed that the translucence of iso-
lated fibers is vastly different between the PGC-1α gain-
of-function and WT mice (Fig 4a, b). This prompted us
to assess the composition of the ECM, which surrounds
muscle fibers, by measuring the gene expression of colla-
gens and glycoproteins (Fig 4c), in particular of those
that comprise the closest layer to the SCs, also called the
BL (Fig 4d). We noticed that several collagens are down-
regulated in mTGs (Fig 4c). In addition, reduced expres-
sion in two components of the BL, fibronectin (FN), and
tenascin C (TNC) was found in mTGs (Fig 4c, d). To
verify whether the reduction in messenger RNA (mRNA)
expression of FN observed in mTGs corresponds to the
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Fig 2 (See legend on next page.)
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protein levels, FN protein concentration was determined
by western blot (Fig 4e). Surprisingly, in contrast to the
reduction observed in gene expression, protein levels of
FN were significantly elevated in mTG animals com-
pared to WTs.
Discussion
SC number, activation, and myogenic potential are mod-
ulated in different physiological and pathophysiological
contexts. For example, the higher number of SCs in oxi-
dative compared to glycolytic muscle beds [10] corre-
lates with the boost in SC numbers by endurance
exercise [11, 12]. We now demonstrate that the coactiva-
tor PGC-1α, a central regulatory nexus in training adap-
tation, modulates SC activation in animals in vivo and in
isolated fiber/SC preparations ex vivo. Intriguingly, this
was achieved in a model that limits PGC-1α overexpres-
sion to adult muscle fibers and therefore does not affect
SCs directly. Accordingly, our data indicate that a PGC-
1α-dependent remodeling of the SC niche affects SC ac-
tivation upon injury.
As a potential explanation, our observations point to-
wards PGC-1α-mediated adaptations in the composition
of the ECM and the BL. Besides a change in collagen gene
expression, we detected significantly reduced transcript
levels of FN (~30% reduction) and TNC (~50% reduction)
in mTG muscles. Surprisingly, despite this PGC-1α-
dependent repression of FN gene expression, the protein
levels of FN were markedly elevated in the mTG muscles.
The cause of this disconnect between gene expression and
protein levels is unclear. The imperative of FN elevation
for SC proliferation and muscle regeneration, as well as its
transient increase in expression upon injury, has been re-
cently reported [8, 9]. Inversely, the complete loss of FN
in the basal state leads to SC loss and reduced prolifera-
tion [8]. Ectopic application of FN to old muscles to coun-
teract age-dependent attenuation of FN confers beneficial
effects on satellite cell function [8]. In fact, some of the ef-
fects that are observed in this model are recapitulated by
the mTGs, in particular the higher satellite cell activation
potential. Elevation of FN within a physiologically benefi-
cial window in the mTGs is implied by the absence of the
(See figure on previous page.)
Fig 2 SC numbers and proliferation on fibers in culture. a Representative IHC images (DAPI/nuclei: blue; MyoD: green; Pax7: red) of SCs on freshly
isolated fibers (T0) and b SC quantification per fiber in mTGs and WT mice. Approximately 60 fibers per mouse and 5 mice per group were used.
c Representative IHC images (DAPI/nuclei: blue; MyoD: green; Pax7: red) of SC progeny on fibers kept for 3 days in culture media (T3).
Quantification results: d Total proliferative output of SCs. e Normalized proliferative output (T3/T0). f Quantification of Pax7+/MyoD−, Pax7+/MyoD
+, and Pax7−/MyoD+ cells per fiber expressed as percentages and g numbers of total proliferative output. Approximately 20 fibers per mouse and
5 mice per group were used. Brightness/contrast was adjusted using ImageJ. Values are plotted as AV ± SEM; *p≤ 0.05, **p≤ 0.01
Fig 3 Myoblast proliferation outside of the SC niche. a Assessment of live mTG and WT myoblasts (MBs) 1 and 2 days after plating equal
numbers and fold change in MB numbers between these two days. Cells were quantified on 10 fields per dish, 2 dishes per mouse, and 3 mice
per genotype. Representative bright-field image with the white rectangle indicating enlarged area. b Desmin-positive cell quantification 2 and
4 days after plating equal number of MBs and fold change between these two days. Cells were quantified on an area of 38.7 mm2 per dish, 2
dishes per mouse, and 3 mice per genotype. Representative IHC image (DAPI/nuclei: red; desmin: green) with the white rectangle indicating
enlarged area. Values are plotted as AV ± SEM
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hallmarks of pathological levels of FN, e.g., the fibrosis
and BL thickening upon chronic elevation of FN in the
uninjured state [7] or the elevated resting SC numbers
and reduced SC proliferative potential on fibers ex vivo
caused by the increased basal expression of FN in like-
acetylglucosaminyltransferase myodystrophy (LARGEmyd)
mice [6].
Besides ECM remodeling, other factors could obvi-
ously also contribute to the observed phenotype. For
example, as a member of the transforming growth factor
β (TGFβ) family, myostatin (Mstn) is an important regu-
lator of fibrosis [23] and muscle mass [24]. In addition,
several studies have reported that Mstn reduces SC and
myoblast proliferation [25–27]. Mstn seems to be
expressed by quiescent SCs [26], but more importantly,
exogenous Mstn can block SC activation and prolifera-
tion in vitro [27]. Intriguingly, Mstn is considerably
downregulated in mTGs even in the basal state, prior to
Fig 4 Extracellular matrix gene expression. a Representative images of freshly isolated fibers from mTGs and WT mice. b Images of WT and mTG
fibers after 3 days in culture media, prior to fixation. WT fibers look translucent and silky while mTG fibers appear matte and with cracks on the
surface. c Relative mRNA levels of ECM components in mTGs and WT mice (n = 6 per group). d Relative mRNA levels of basal lamina (BL)
components in mTGs and WT mice (n = 6 per group). e Western blot analysis and quantification of fibronectin normalized to α-tubulin levels.
Values are plotted as AV ± SEM; *p≤ 0.05, **p ≤ 0.01, ***p≤ 0.001
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injury (Additional file 5). Thus, Mstn could mediate
some of the effects of muscle PGC-1α on SC activation
and thus provide an explanation for the regulation of
Mstn by PGC-1α in the absence of changes in muscle
mass in the mTGs [28]. However, the functional contri-
bution of Mstn and potentially other secreted factors in
this context will have to be studied in more detail.
Very surprisingly, the fiber-type shift mediated by
muscle PGC-1α was not linked to an increase in SC
numbers, as would be expected from more oxidative or
endurance-trained muscle beds. In fact, transgenic over-
expression of PGC-1α consistently resulted in lower SC
counts, both in muscle in vivo and in fiber/SC prepara-
tions ex vivo. This divergence is one of the very few pa-
rameters for which the PGC-1α-overexpressing and
bona fide oxidative fibers are clearly different. In regard
to most other metabolic and contractile properties, skel-
etal muscles of mTG animals closely mimic the pheno-
type of oxidative muscles [29]. Thus, the mechanistic
underpinnings that control the diametrically opposite
outcome between PGC-1α-overexpressing fibers with
low vis-à-vis oxidative and endurance-trained muscle
with high SC count is unclear. Importantly, this reduc-
tion in SC numbers was however offset by the higher
proliferative potential of SCs in the mTG animals. At
least this aspect could represent the contribution of
muscle PGC-1α to SC biology in exercise.
Conclusions
In summary, we now for the first time provide evidence
for a PGC-1α-dependent stem cell niche remodeling that
alters SC activation and proliferation. We identified fi-
bronectin as a potential niche factor influencing the SC
response to injury, whose gene expression and protein
levels are inversely modulated by PGC-1α. Increasing SC
proliferation would be of great therapeutic benefit in
various muscle-wasting pathologies and aging, where re-
duced SC myogenic capacity impairs effective muscle re-
generation. More importantly, our results indicate that
this outcome could be achieved without directly ma-
nipulating SCs. This could be especially advantageous in
stem cell-based transplantation to optimize therapeutic
solutions.
Additional files
Additional file 1: List of qPCR primers.
Additional file 2: Kinetics of Pax7 and MRF gene expression after
cardiotoxin injury. Relative mRNA expression of A) Pax7, B) MyoD, C) Myog,
and D) MRF-4 2 days (n = 4–5 per group), 4 days (n = 7–8 per group), 7 days
(n = 5 per group), 10 days (n = 8 per group), and 19 days (n = 8–10 per
group) post-CTX injection in mTGs and WT mice. Expression levels from CTX
samples were normalized to PBS sample levels of corresponding genotype.
Values are plotted as AV ± SEM; *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001.
Additional file 3: In situ TA contractility measurements 16 days and fiber
size distribution 19 days after cardiotoxin injection. A) Absolute maximal
force (P0), B) specific force (P0/weight), and C) fatigue resistance in mTGs
and WT mice 16 days after CTX; n = 7–8 per group. Feret minimum
measurements 19 days after injections in D) PBS- and E) CTX-injected TAs;
n = 8–10 per group; Values are plotted as AV ± SEM; * p≤ 0.05.
Additional file 4: Regeneration after multiple cardiotoxin injections. A)
SC numbers 3 weeks after the last injection in WT and mTG TAs and fold
change normalized to triple PBS-injected samples. Feret minimum
measurements after multiple injections in B) PBS- and C) CTX-injected
TAs; n = 7–9 per group; Values are plotted as AV ± SEM; *p≤ 0.05,
**p≤ 0.01.
Additional file 5: Mstn expression in WT and mTG muscles. Relative Mstn
mRNA levels in the basal state in TAs of WT mice and mTGs; n = 5–6 per
group. Values are plotted as AV ± SEM; ***p≤ 0.001.
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